,

Nattokinase vs Serrapeptase: Compare the Human Evidence

Erin Behan
Reviewed by

Erin Behan

Runner silhouetted against a sunrise on a rocky ridge

Nattokinase and serrapeptase are different protein-breaking enzymes with different research histories. Nattokinase has more human research on blood-related markers, while serrapeptase has been studied mainly in specific, short-term clinical settings.

The useful comparison is what each enzyme has demonstrated in people. A capsule’s ability to break down a protein in a lab does not tell you what it will do throughout your body.

Nattokinase comes from natto fermentation, while serrapeptase is produced by bacteria.

Enzyme activity in a laboratory does not establish a health benefit from an oral supplement.

Nattokinase trials report mixed results, and serrapeptase evidence depends heavily on the setting studied.

Medication use, bleeding risk, and the full formula deserve review before you choose either enzyme.

Two Enzymes With Different Starting Points

Nattokinase is an enzyme produced during soybean fermentation, while serrapeptase is a bacterial enzyme also called serratiopeptidase. Both are proteases, which means they break particular bonds within proteins.

Nattokinase research often examines fibrin, a protein involved in the body’s normal clotting process. The body also has a normal process for breaking fibrin down, called fibrinolysis. Researchers study whether oral nattokinase changes markers of that process.

Serrapeptase belongs to a different enzyme family. Its research includes protein breakdown and short-term outcomes in people receiving clinical care. A systematic review of serratiopeptidase found substantial weaknesses in the evidence available for its broader proposed uses.

These enzymes are also different from tissue-specific peptide complexes. If those categories get blurred, our explanation of peptide bioregulators provides the background. The comparison here stays with enzyme supplements.

Nattokinase vs Serrapeptase at a Glance

Choose a comparison based on the research question and the product label, rather than a shared marketing term such as “systemic enzyme.” These five distinctions explain why the two ingredients are not interchangeable.

FactorNattokinaseSerrapeptasePractical Meaning
OriginNatto fermentationBacterial fermentationCheck identity and sourcing.
Research focusBlood and vascular markersSpecific short-term clinical outcomesMatch the study to the goal.
Human findingsMixed across study designsLimited and setting-specificA broad benefit claim needs evidence.
Label detailsIdentity and activity unitsIdentity, activity units, deliveryWeight alone does not show activity.
Safety reviewBleeding risk and medication overlapMedication overlap and limited long-term dataReview the whole formula.

What Nattokinase Has Shown in People

Nattokinase has demonstrated changes in some blood markers, but its longer-term trial results are mixed. Study size and the outcome measured make a real difference to what you can conclude.

In a randomized crossover study of 12 healthy men, researchers observed changes in several clotting and fibrin-breakdown markers after nattokinase. The changes stayed within normal ranges. This was a short laboratory-marker study, not a test of long-term health outcomes.

A 2023 meta-analysis of six trials involving 546 participants found lower average blood pressure with nattokinase than with placebo. The review did not establish a consistent improvement in cholesterol or triglycerides. The populations and study designs also varied.

The longer Nattokinase Atherothrombotic Prevention Study followed 265 adults for a median of three years. It found no significant differences in the progression of the artery measurements it tracked, blood pressure, or laboratory results.

Those results place a useful boundary around the ingredient. There is human research worth examining, but a change in a blood marker cannot establish that an enzyme protects someone from a future cardiovascular event.

If your blood pressure is healthy and you want to keep it that way, that is a different goal from managing a diagnosed problem. Ongoing changes in blood pressure or circulation symptoms need a medical check, not a new supplement.

Why Serrapeptase Studies Need Their Context

Serrapeptase research is concentrated in specific clinical settings, so its findings should stay tied to those settings. A study of recovery after a procedure cannot establish broad daily-wellness benefits.

The broad systematic review mentioned above examined 24 clinical efficacy studies. It identified problems such as small samples, unclear outcomes, and incomplete safety information. The authors concluded that the existing evidence did not adequately support the broad health-supplement claims being made.

A later systematic review of five studies after molar surgery reported a favorable result for restricted mouth opening in one comparison. Other outcomes were harder to resolve, and too few studies were available for several comparisons.

That is a narrow finding in people receiving dental care. It does not show that a serrapeptase capsule clears scar tissue throughout the body, improves everyday joint comfort, or provides a general cardiovascular benefit.

Exercise and nutrition remain central to maintaining muscle as you age. For a different approach to muscle-aging research, read our guide to Gotratix and muscle aging.

What an Activity Number Can Tell You

An enzyme label should identify the ingredient and its measured activity. Capsule weight alone cannot tell you how much protein-breaking activity a product contains.

Activity units describe performance in a defined laboratory test. They can help characterize a product, but they do not measure a person’s expected benefit. Different enzyme tests use different substrates and conditions, so numbers printed for different enzymes are not a universal potency scale.

Use the label to answer a short set of questions:

  • Is the exact enzyme identified, rather than hidden within a generic blend?
  • Does the manufacturer explain the activity measurement and testing method?
  • Are the other active ingredients clearly listed?
  • Can you obtain a batch-specific report for identity, activity, and relevant contaminants?
  • Does the evidence apply to the same ingredient and formulation?

Delivery claims need evidence too. A coating or absorption claim may describe how a product is designed, but it does not by itself demonstrate a clinical result. A study of one formulation cannot automatically validate every capsule sold under the same enzyme name.

Our ingredients library can help you identify unfamiliar compounds in a blend. Use that information alongside the full label and the actual research, rather than selecting a product by the biggest activity number.

Can You Take Nattokinase and Serrapeptase Together?

Combining the enzymes does not establish that the combination works better. It also makes tolerance, interactions, and the contribution of each ingredient harder to assess.

A multi-ingredient trial can support a conclusion about the tested formula, but it cannot isolate the effects of every ingredient. This matters when an enzyme blend includes antioxidants, other proteases, or ingredients with their own medication interactions.

Ask a clinician or pharmacist to review the complete formula if you take an anticoagulant or antiplatelet medicine, have a bleeding disorder, or are preparing for a procedure. Include nonprescription medicines and other supplements in that discussion.

Long-term safety information is limited for serrapeptase. Small trials that report few adverse events cannot establish safety for every person, medication combination, or length of use. Neither ingredient should be used to replace prescribed care.

Frequently Asked Questions

These answers keep the decision focused on the ingredient, evidence, and full product.

Is Serrapeptase the Same as Serratiopeptidase?

Yes. Serrapeptase and serratiopeptidase are names used for the same enzyme. Checking both terms can help you find the research behind a label.

Is Nattokinase the Same as Eating Natto?

No. Natto is a fermented food with several nutrients and compounds. A nattokinase supplement is an enzyme preparation, so research on one cannot automatically establish the effects of the other.

Which Enzyme Has More Human Research?

Nattokinase has more human trials directly examining vascular and blood-related markers. Serrapeptase has clinical research in narrower settings. Neither evidence base establishes a universal best choice.

Does a Higher Activity Number Mean Better Results?

No. It describes activity under test conditions. The relationship between that number and a health outcome has to be demonstrated in people using the relevant formulation.

Can Either Enzyme Be Used With Blood Thinners?

Do not add an enzyme supplement on your own if you use anticoagulant or antiplatelet medication. A clinician or pharmacist needs to assess bleeding risk and every active ingredient in the product.

Final Takeaway

Nattokinase deserves attention for its human biomarker research, while serrapeptase needs a much more specific explanation of the setting and outcome studied. Your next step is to define the goal, check the evidence, and review the full formula.

Our BioPurify formula includes nattokinase alongside red yeast rice, CoQ10, NAC, and other active ingredients. Nattokinase may add to the effect of blood thinners and red yeast rice can act like a statin, so talk to your clinician first if you take either. See the complete ingredient list on the product page.

Ask for the batch Certificate of Analysis (COA) before you buy. Our editorial review standards explain how we develop educational content and assess the research behind it.

This article is educational and does not replace medical advice. Ask a qualified clinician before starting any supplement if you are pregnant, nursing, taking medication, or managing a medical condition.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.


References

  1. Bhagat S, Agarwal M, Roy V. Serratiopeptidase: a systematic review of the existing evidence. International Journal of Surgery. 2013;11(3):209-217. DOI.
  2. Kurosawa Y, Nirengi S, Homma T, et al. A single-dose of oral nattokinase potentiates thrombolysis and anti-coagulation profiles. Scientific Reports. 2015;5:11601. DOI.
  3. Li X, Long J, Gao Q, et al. Nattokinase Supplementation and Cardiovascular Risk Factors: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Reviews in Cardiovascular Medicine. 2023;24(8):234. DOI.
  4. Hodis HN, Mack WJ, Meiselman HJ, et al. Nattokinase atherothrombotic prevention study: A randomized controlled trial. Clinical Hemorheology and Microcirculation. 2021. DOI.
  5. Sivaramakrishnan G, Sridharan K. Role of Serratiopeptidase After Surgical Removal of Impacted Molar: A Systematic Review and Meta-analysis. Journal of Maxillofacial and Oral Surgery. 2018;17(2):122-128. DOI.